Health Care

Commentary

Learn about states and Medicaid disenrollment

States Are Wasting Money by Slow-Rolling Medicaid Reviews

During the COVID-19 public health emergency, Congress forbade states from disenrolling people from Medicaid. The idea was to prevent people from losing coverage during the pandemic. But the emergency is over. On April 1, state Medicaid programs regained the ability to drop people no longer eligible. Some states have moved ...
Covid-19

Wayne Winegarden on Lars Larson Show: Did Covid Restrictions Wreck Our Economy For Nothing?

Listen to Dr. Wayne Winegarden, PRI senior fellow in business and economics and director of PRI’s Center for Medical Economics and Innovation, discuss his new brief “No Solutions, Only Tradeoffs,” which explores how the small health benefits generated by state COVID-19 lockdowns were more than offset by huge losses in ...
Commentary

Read about problems with drug price controls

Inflation Reduction Act kills incentives for medical innovation

The Biden administration recently announced the first 10 drugs that will be subject to price controls under Medicare as part of the Inflation Reduction Act. The president celebrated the occasion, saying, “We took on Big Pharma and special interests, overcoming opposition from every Republican in Congress, and the American people ...
Commentary

Read latest about problems with Obamacare

Will Dems Ever Own Up to Obamacare Failure?

Exchange coverage is far more expensive than originally predicted. It’s also proved difficult for beneficiaries to put to use. In short, Democrats have engineered an insurance marketplace that serves the interests of neither taxpayers nor patients. And they’ve spent lavishly to keep it running. Click to read the full article ...
Commentary

Read about Medicare spending

Congress must rein in spending by cutting costs in Medicare and Medicaid

Enrollment in Medicaid has skyrocketed, largely due to Obamacare’s Medicaid expansion and a pandemic-era prohibition on disenrolling people from the program. As of June 2023, Medicaid and the related Children’s Health Insurance Program covered nearly 93 million people — a 60% increase relative to the pre-Obamacare figure . Read the ...
Covid-19

Wayne Winegarden – The Impact of Covid-19 Restrictions

Our guest this week is PRI senior fellow Dr. Wayne Winegarden.  We discuss with Wayne his new study comparing the results of states that had very restrictive COVID-19 policies versus those that did not.  He concludes that while COVID-19 restrictions did lead to some health benefits, they were unfortunately negated ...
Commentary

Read about the importance of drug price transparency

Transparency Is The Cure For What Ails American Health Care

A government shutdown has been averted—for now. Congress approved a continuing resolution this weekend that funds the government through mid-November. But the weeks-long fight put other important legislative work on hold. Take the “Lower Costs, More Transparency Act.” Late last month, lawmakers pulled it from the floor ahead of an ...
Commentary

Read about benefits of health savings accounts

A Boom in Health Savings Accounts Can Save Our Health System

A bill introduced last week by Reps. Greg Steube, R-Fla., and Kat Cammack, R-Fla., could change that. The ACCESS Act allows people to accept federal contributions to an HSA in lieu of reduced cost-sharing for insurance purchased through an exchange. The reform would bring the benefits of HSAs to millions ...
Commentary

Read about problems with drug price controls

Let’s Hope Drug Companies Win Price Controls War

The IRA gives federal officials the authority to dictate what Medicare pays for certain medicines — a scheme intended to reduce the government’s drug bill. Late last month, the Department of Health and Human Services announced the first 10 drugs subject to the law’s price controls, which include the blood thinners ...
Coronavirus

NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses

States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click ...
Commentary

Learn about states and Medicaid disenrollment

States Are Wasting Money by Slow-Rolling Medicaid Reviews

During the COVID-19 public health emergency, Congress forbade states from disenrolling people from Medicaid. The idea was to prevent people from losing coverage during the pandemic. But the emergency is over. On April 1, state Medicaid programs regained the ability to drop people no longer eligible. Some states have moved ...
Covid-19

Wayne Winegarden on Lars Larson Show: Did Covid Restrictions Wreck Our Economy For Nothing?

Listen to Dr. Wayne Winegarden, PRI senior fellow in business and economics and director of PRI’s Center for Medical Economics and Innovation, discuss his new brief “No Solutions, Only Tradeoffs,” which explores how the small health benefits generated by state COVID-19 lockdowns were more than offset by huge losses in ...
Commentary

Read about problems with drug price controls

Inflation Reduction Act kills incentives for medical innovation

The Biden administration recently announced the first 10 drugs that will be subject to price controls under Medicare as part of the Inflation Reduction Act. The president celebrated the occasion, saying, “We took on Big Pharma and special interests, overcoming opposition from every Republican in Congress, and the American people ...
Commentary

Read latest about problems with Obamacare

Will Dems Ever Own Up to Obamacare Failure?

Exchange coverage is far more expensive than originally predicted. It’s also proved difficult for beneficiaries to put to use. In short, Democrats have engineered an insurance marketplace that serves the interests of neither taxpayers nor patients. And they’ve spent lavishly to keep it running. Click to read the full article ...
Commentary

Read about Medicare spending

Congress must rein in spending by cutting costs in Medicare and Medicaid

Enrollment in Medicaid has skyrocketed, largely due to Obamacare’s Medicaid expansion and a pandemic-era prohibition on disenrolling people from the program. As of June 2023, Medicaid and the related Children’s Health Insurance Program covered nearly 93 million people — a 60% increase relative to the pre-Obamacare figure . Read the ...
Covid-19

Wayne Winegarden – The Impact of Covid-19 Restrictions

Our guest this week is PRI senior fellow Dr. Wayne Winegarden.  We discuss with Wayne his new study comparing the results of states that had very restrictive COVID-19 policies versus those that did not.  He concludes that while COVID-19 restrictions did lead to some health benefits, they were unfortunately negated ...
Commentary

Read about the importance of drug price transparency

Transparency Is The Cure For What Ails American Health Care

A government shutdown has been averted—for now. Congress approved a continuing resolution this weekend that funds the government through mid-November. But the weeks-long fight put other important legislative work on hold. Take the “Lower Costs, More Transparency Act.” Late last month, lawmakers pulled it from the floor ahead of an ...
Commentary

Read about benefits of health savings accounts

A Boom in Health Savings Accounts Can Save Our Health System

A bill introduced last week by Reps. Greg Steube, R-Fla., and Kat Cammack, R-Fla., could change that. The ACCESS Act allows people to accept federal contributions to an HSA in lieu of reduced cost-sharing for insurance purchased through an exchange. The reform would bring the benefits of HSAs to millions ...
Commentary

Read about problems with drug price controls

Let’s Hope Drug Companies Win Price Controls War

The IRA gives federal officials the authority to dictate what Medicare pays for certain medicines — a scheme intended to reduce the government’s drug bill. Late last month, the Department of Health and Human Services announced the first 10 drugs subject to the law’s price controls, which include the blood thinners ...
Coronavirus

NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses

States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click ...
Scroll to Top